Search
Menu

News

Discover the latest news stories, blog posts and publications from Cobra's expert team

Home / News

Posts by Tag

See all

or

Posts by Tag

See all

INTERVIEW: Thomas Moore, Sky News, reports on the fight against COVID-19

Biologics manufacturing capacity and the challenges of scaling up vaccine production to fast track one million doses by September Biologics manufacturing capacity and the challenges of scaling up vaccine production to fast track one million doses by September

INTERVIEW: Andrew Marr with Prof. Sarah Gilbert, vaccinologist at Oxford University

Cobra is proud to be part of a consortium, led by the Jenner Institute, Oxford University to rapidly develop a COVID-19 vaccine Cobra is proud to be part of a consortium, led by the Jenner Institute, Oxford University to rapidly develop a COVID-19 vaccine

BLOG: COVID-19 Vaccine Hopes and Hurdles

Cobra has been fortunate to be given the opportunity to work with two novel vaccine candidates against COVID-19, utilising the company’s knowledge and experience in the production... Cobra Biologics has been fortunate to be given the opportunity to work with two novel vaccine candidates against COVID-19, utilising the company’s knowledge and experience in the production of plasmid DNA and viral vaccines. This blog aims to give a short introduction into the different types of vaccines that are in use, including the platform approaches relating to these two candidates and to highlight some of the potential manufacturing and

Cobra Biologics successfully completes key milestone in CombiGene’s epilepsy project CG01 with delivery of first DNA plasmid

Production method of plasmids developed and first plasmid produced for gene therapy drug candidate aimed at treating drug resistant focal epilepsy Production method of plasmids developed and first plasmid produced for gene therapy drug candidate aimed at treating drug resistant focal epilepsy